What is the share price of Indrayani Biotech Ltd (INDRANIB) today?
The share price of INDRANIB as on 16th July 2025 is ₹14.07. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indrayani Biotech Ltd (INDRANIB) share?
The past returns of Indrayani Biotech Ltd (INDRANIB) share are- Past 1 week: -10.05%
- Past 1 month: -9.29%
- Past 3 months: -29.65%
- Past 6 months: -58.86%
- Past 1 year: -73.55%
- Past 3 years: -68.02%
- Past 5 years: 67.90%
What are the peers or stocks similar to Indrayani Biotech Ltd (INDRANIB)?
The peers or stocks similar to Indrayani Biotech Ltd (INDRANIB) include:What is the market cap of Indrayani Biotech Ltd (INDRANIB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indrayani Biotech Ltd (INDRANIB) is ₹64.02 Cr as of 16th July 2025.What is the 52 week high and low of Indrayani Biotech Ltd (INDRANIB) share?
The 52-week high of Indrayani Biotech Ltd (INDRANIB) is ₹60.50 and the 52-week low is ₹13.01.What is the PE and PB ratio of Indrayani Biotech Ltd (INDRANIB) stock?
The P/E (price-to-earnings) ratio of Indrayani Biotech Ltd (INDRANIB) is -14.13. The P/B (price-to-book) ratio is 0.84.Which sector does Indrayani Biotech Ltd (INDRANIB) belong to?
Indrayani Biotech Ltd (INDRANIB) belongs to the Information Technology sector & Software Services sub-sector.How to buy Indrayani Biotech Ltd (INDRANIB) shares?
You can directly buy Indrayani Biotech Ltd (INDRANIB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indrayani Biotech Ltd
INDRANIB Share Price
INDRANIB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDRANIB Performance & Key Metrics
INDRANIB Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-15.58 | 0.84 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
28.36 | 7.72 | 2.57% |
INDRANIB Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
INDRANIB Company Profile
Indrayani Biotech is engaged in providing travel technology and solutions.
INDRANIB Forecast
INDRANIB Forecasts
INDRANIB
INDRANIB
Income
Balance Sheet
Cash Flow
INDRANIB Income Statement
INDRANIB Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 50.10 | 21.36 | 61.79 | 167.42 | 167.44 | 133.35 | 133.35 | |||||||
Raw Materials | 32.48 | 15.77 | 41.04 | 102.21 | 97.13 | 123.97 | 123.97 | |||||||
Power & Fuel Cost | 0.48 | 0.33 | 0.34 | 6.08 | 6.70 | |||||||||
Employee Cost | 10.81 | 5.39 | 9.58 | 23.01 | 23.07 | |||||||||
Selling & Administrative Expenses | 2.09 | 3.60 | 2.69 | 7.77 | 6.73 | |||||||||
Operating & Other expenses | 1.26 | 5.05 | 1.15 | 7.04 | 8.94 | |||||||||
EBITDA | 2.98 | -8.78 | 6.99 | 21.31 | 24.87 | 9.38 | 9.38 | |||||||
Depreciation/Amortization | 1.01 | 0.46 | 0.66 | 3.35 | 3.80 | 3.37 | 3.36 | |||||||
PBIT | 1.97 | -9.24 | 6.33 | 17.96 | 21.07 | 6.01 | 6.02 | |||||||
Interest & Other Items | 1.15 | 1.97 | 1.89 | 5.64 | 10.10 | 11.76 | 11.77 | |||||||
PBT | 0.82 | -11.21 | 4.44 | 12.32 | 10.97 | -5.75 | -5.75 | |||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 3.56 | 4.61 | -1.22 | -1.64 | |||||||
Net Income | 0.82 | -11.21 | 4.44 | 8.76 | 6.36 | -4.53 | -4.11 | |||||||
EPS | 2.25 | -5.92 | 1.30 | 2.56 | 1.59 | -1.35 | -0.90 | |||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
INDRANIB Company Updates
INDRANIB Stock Peers
INDRANIB Past Performance & Peer Comparison
INDRANIB Past Performance & Peer Comparison
Information TechnologySoftware Services
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Indrayani Biotech Ltd | -14.13 | 0.84 | — |
Persistent Systems Ltd | 61.95 | 13.73 | 0.63% |
Oracle Financial Services Software Ltd | 32.19 | 9.16 | 3.01% |
L&T Technology Services Ltd | 36.37 | 7.55 | 1.26% |
INDRANIB Stock Price Comparison
Compare INDRANIB with any stock or ETFINDRANIB Holdings
INDRANIB Shareholdings
INDRANIB Promoter Holdings Trend
INDRANIB Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
INDRANIB Institutional Holdings Trend
INDRANIB Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRANIB Shareholding Pattern
INDRANIB Shareholding Pattern
INDRANIB Shareholding History
INDRANIB Shareholding History
smallcases containing INDRANIB stock
smallcases containing INDRANIB stock
Looks like this stock is not in any smallcase yet.
INDRANIB Events
INDRANIB Events
INDRANIB Dividend Trend
INDRANIB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
INDRANIB Dividend Trend
INDRANIB has not given any dividends in last 5 years
INDRANIB Dividends
INDRANIB Dividends
INDRANIB Stock News & Opinions
INDRANIB Stock News & Opinions
Net loss of Indrayani Biotech reported to Rs 5.81 crore in the quarter ended March 2025 as against net profit of Rs 3.87 crore during the previous quarter ended March 2024. Sales rose 13.95% to Rs 50.57 crore in the quarter ended March 2025 as against Rs 44.38 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 4.52 crore in the year ended March 2025 as against net profit of Rs 6.36 crore during the previous year ended March 2024. Sales declined 21.66% to Rs 130.23 crore in the year ended March 2025 as against Rs 166.23 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales50.5744.38 14 130.23166.23 -22 OPM %-11.3522.94 -4.8114.11 - PBDT-10.035.69 PL -2.3814.78 PL PBT-8.324.73 PL -5.7410.97 PL NP-5.813.87 PL -4.526.36 PL Powered by Capital Market - Live
Net profit of Indrayani Biotech rose 1485.71% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 0.07 crore during the previous quarter ended March 2024. Sales declined 41.27% to Rs 9.28 crore in the quarter ended March 2025 as against Rs 15.80 crore during the previous quarter ended March 2024. For the full year,net profit declined 0.68% to Rs 1.45 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 39.39% to Rs 37.77 crore in the year ended March 2025 as against Rs 62.32 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales9.2815.80 -41 37.7762.32 -39 OPM %18.536.27 -14.489.10 - PBDT0.261.97 -87 1.674.46 -63 PBT0.201.62 -88 0.653.01 -78 NP1.110.07 1486 1.451.46 -1 Powered by Capital Market - Live
Indrayani Biotech has adjourned the meeting of the Board of Directors which was scheduled to be held on 9 June 2025. The meeting will now be held on 12 June 2025.Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 9 June 2025.Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 3 April 2025.Powered by Capital Market - Live
Net profit of Indrayani Biotech declined 75.51% to Rs 0.24 crore in the quarter ended December 2024 as against Rs 0.98 crore during the previous quarter ended December 2023. Sales declined 55.69% to Rs 17.32 crore in the quarter ended December 2024 as against Rs 39.09 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales17.3239.09 -56 OPM %16.868.80 - PBDT1.892.12 -11 PBT0.431.08 -60 NP0.240.98 -76 Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
Net profit of Indrayani Biotech declined 77.98% to Rs 1.22 crore in the quarter ended September 2024 as against Rs 5.54 crore during the previous quarter ended September 2023. Sales declined 23.81% to Rs 30.81 crore in the quarter ended September 2024 as against Rs 40.44 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.8140.44 -24 OPM %16.5918.05 - PBDT3.996.45 -38 PBT1.205.54 -78 NP1.225.54 -78 Powered by Capital Market - Live
Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Net profit of Indrayani Biotech reported to Rs 0.85 crore in the quarter ended June 2024 as against net loss of Rs 0.45 crore during the previous quarter ended June 2023. Sales declined 25.48% to Rs 31.53 crore in the quarter ended June 2024 as against Rs 42.31 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales31.5342.31 -25 OPM %12.625.98 - PBDT1.770.52 240 PBT0.94-0.38 LP NP0.85-0.45 LP Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 21.63%, vs industry avg of 13.64%
Over the last 5 years, market share increased from 0.13% to 0.18%